Literature DB >> 11445741

Microvascular coagulopathy and disseminated intravascular coagulation.

H ten Cate1, S H Schoenmakers, R Franco, J J Timmerman, A P Groot, C A Spek, P H Reitsma.   

Abstract

OBJECTIVE: To review the dual characteristics of disseminated intravascular coagulation (DIC), as both a contributor to multiple organ failure as well as a symptom of severe underlying disease associated with systemic vascular changes. DATA SOURCES: Published literature data and unpublished results from the authors. DATA
SUMMARY: Clinical and experimental studies strongly suggest that DIC contributes to multiple organ failure and death in patients with severe systemic disorders such as sepsis. DIC is evoked by systemic cytokine activity, and the inflammatory response aggravates vascular permeability, inflammation, and cell damage in tissues. In addition to intravascular fibrin formation, thrombin and fibrin generation in tissues is also an important aspect of DIC. An example of DIC at the organ level is adult respiratory distress syndrome, where fibrin in the lung is a characteristic feature. Intravascular fibrin formation and occlusion may elicit a hypoxic response with induction of hypoxia related transcription factors. The resulting ischemic preconditioning may offer protective effects to the involved organ(s).
CONCLUSIONS: Overall, the beneficial or harmful effects of activated coagulation and fibrin formation for organ pathology and recovery from DIC remain to be explored. This may be a critical element in the assessment of ischemia-reperfusion effects of specific anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445741     DOI: 10.1097/00003246-200107001-00030

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  10 in total

Review 1.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

Review 2.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 3.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 4.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

5.  Modified score for disseminated intravascular coagulation in the critically ill.

Authors:  Mirka Sivula; Minna Tallgren; Ville Pettilä
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

6.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

7.  Systemic coagulation parameters in mice after treatment with vascular targeting agents.

Authors:  Maike Unruh; Andrea Grunow; Claudia Gottstein
Journal:  Thromb J       Date:  2005-12-10

8.  Systemic hypothermia increases PAI-1 expression and accelerates microvascular thrombus formation in endotoxemic mice.

Authors:  Nicole Lindenblatt; Michael D Menger; Ernst Klar; Brigitte Vollmar
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  Cutaneous Manifestations in COVID-19-Positive African American Patients.

Authors:  Avery Bryan; Hrishikesh Samant; Ameya Asarkar; Cherie-Ann O Nathan; Alok Khandelwal
Journal:  Ochsner J       Date:  2022

10.  Characterization and pharmacological properties of a novel multifunctional Kunitz inhibitor from Erythrina velutina seeds.

Authors:  Richele J A Machado; Norberto K V Monteiro; Ludovico Migliolo; Osmar N Silva; Michele F S Pinto; Adeliana S Oliveira; Octávio L Franco; Sumika Kiyota; Marcelo P Bemquerer; Adriana F Uchoa; Ana H A Morais; Elizeu A Santos
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.